Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB – PR Newswire (press release)
|
Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB
PR Newswire (press release) Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that a research collaboration agreement has been signed with Professor Ignacio … |
